Carrie Brownstein
Chief Medical OfficerDr. Carrie Brownstein, M.D., is Chief Medical Officer of Kyntra Bio, Inc. from August 2026. She was Chief Medical Officer of Onchilles Pharma, Inc. until November 2025. Dr. Brownstein serves as Chief Medical Officer at Zentalis Pharmaceuticals, Inc. since October 3, 2022 until January 2024. She served as an Independent Director at Shattuck Labs, Inc. since October 2021 until August 25, 2025. She served as Chief Medical Officer at Cellectis S. A. since April 2020 until 2022. Dr. Brownstein joined Cellectis in April 2020 as a seasoned clinical and medical expert from Celgene, where she served as Vice President of Global Clinical Research and Development, Therapeutic Area Head for myeloid diseases from March 2017 to April 2020. Prior to Celgene, Dr. Brownstein served as Executive Director of Clinical Sciences Oncology at Regeneron Pharmaceuticals where she led teams investigating multiple early development programs and assets, including T-cell engaging bispecific antibodies from August 2012 to March 2017. Dr. Brownstein started her industry career at Hoffman-La Roche (Roche Pharmaceuticals), where she held roles of increasing responsibility and served as and Senior Medical Director of Hematology and Oncology at F. Hoffmann-La Roche AG (OTCMKTS: RHHBY), a pharmaceutical company, from September 2006 to August 2012. Prior to her career in an industry setting, Dr. Brownstein practiced medicine as a pediatric oncologist within notable New York institutions such as New York Presbyterian Columbia University and Mount Sinai Medical Center. Dr. Brownstein received her M. D. from Tufts University School of Medicine and completed her internship and residency at the Babies and Children’s Hospital of Columbia Presbyterian Medical Center. She completed a fellowship in pediatric hematology and oncology at Memorial Sloan-Kettering Cancer Center. She received her A. B. in Psychology from the University of Michigan.
Positions
- Company NameKyntra Bio, Inc.Stock CodeKYNBPositionChief Medical OfficerColleagues
- TWThane WettigCEO & Director
- JAJames A. SchoeneckIndependent Chairman of the Board
- DDDavid DeLuciaSenior VP & CFO
- JAJohn AldenCorporate Secretary & General Counsel
- MSMichelle SimonettiHead of People and Culture & Executive Director
- JLJeffrey L. EdwardsIndependent Director
- MGMichael Glen KauffmanIndependent Director
- AEAndrew E. SingerIndependent Director
